The present invention relates to 2-aminocarbonyl-pyridine derivatives ofFormula (I) and their use as P2Y12 receptorantagonists in the treatment and/or prevention of peripheral vascular, ofvisceral-, hepatic- and renal-vascular, of cardiovascular andof cerebrovascular diseases or conditions associated with plateletaggregation, including thrombosis.